Becton, Dickinson & Co. (BDX)
176.48
-0.18
(-0.10%)
USD |
NYSE |
Feb 27, 16:00
176.66
+0.18
(+0.10%)
Pre-Market: 06:18
Becton, Dickinson Research and Development Expense (Annual) : 1.265B for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Baxter International, Inc. | 503.00M |
| Abbott Laboratories | 2.889B |
| Boston Scientific Corp. | 2.052B |
| West Pharmaceutical Services, Inc. | 74.30M |
| Integra LifeSciences Holdings Corp. | 36.48M |